-
PurposeGateway-compatible entry vector for direct cloning of synthetic trans-acting siRNAs into Arabidopsis thaliana TAS1c precursor
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 51774 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepENTR
- Backbone size w/o insert (bp) 2580
- Total vector size (bp) 4989
-
Vector typeGATEWAY-compatible entry clone
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol and Kanamycin, 25 & 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DB3.1
-
Growth instructionsE. coli DB3.1 (or other strain resistant to ccdB) at 37C
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAtTAS1c-B/c
-
SpeciesA. thaliana (mustard weed)
-
Insert Size (bp)2409
-
MutationA. thaliana TAS1c precursor sequence including a chloramphenicol-ccdB cassette flanked by two inverted BsaI sites. The BsaI site in the ccdB gene was mutated to block the site.
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer M13-F20
- 3′ sequencing primer M13-Rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pENTR-AtTAS1c-B/c was a gift from James Carrington (Addgene plasmid # 51774 ; http://n2t.net/addgene:51774 ; RRID:Addgene_51774) -
For your References section:
New Generation of Artificial MicroRNA and Synthetic Trans-Acting Small Interfering RNA Vectors for Efficient Gene Silencing in Arabidopsis. Carbonell A, Takeda A, Fahlgren N, Johnson SC, Cuperus JT, Carrington JC. Plant Physiol. 2014 Mar 19. 10.1104/pp.113.234989 PubMed 24647477